• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孟加拉国达卡化脓性汗腺炎的患病率:一项基于医院的研究。

Prevalence of Hidradenitis Suppurativa in Dhaka, Bangladesh: A Hospital-Based Study.

作者信息

Bhuiyan Mohammed Saiful Islam, Noor Towhida, Akhter Sania, Tahnin Nur-A-Tasmin, Bouazzi Dorra, Medianfar Cecilia E, Christensen Robin, Jemec Gregor B E

机构信息

Department of Dermatology and Venereology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.

Department of Dermatology and Venereology, Metador Diagnostic and Wellness Center, Dhaka, Bangladesh.

出版信息

Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000538444.

DOI:10.1159/000538444
PMID:40623401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12233970/
Abstract

BACKGROUND

The prevalence of hidradenitis suppurativa (HS) varies widely in different epidemiologic studies from different parts of the world and very few data are available from South Asia.

OBJECTIVES

The aim of this study was to determine the prevalence of HS in Dhaka, Bangladesh.

METHODS

An exploratory, cross-sectional, and descriptive study was done among 2,500 consecutive healthy accompanying adults of patients attending at the outpatient department (except dermatology), at the Bangabandhu Sheikh Mujib Medical University Hospital, Dhaka, Bangladesh. This was an initiative of Global Hidradenitis Suppurativa Atlas (GHiSA), and it therefore followed the approach previously published by Bouazzi et al. Results: Out of a total of 2,377 accompanying persons, 3 were diagnosed with HS. The point prevalence was 0.13% (CI: 0.04%-0.37%), sensitivity was 0.1 (3/3), specificity was 0.1 (23/23), positive predictive value positive predictive value (PPV) was 0.1 (3/3), and the negative predictive value was 0.1 (23/23). The median age of the HS patients was 45.0, and the median BMI was 28.0. All 3 confirmed HS were male.

CONCLUSIONS

The prevalence of HS in Bangladesh is lower than in western countries and other GHiSA studies like Singapore, Ghana, and Greenland.

摘要

背景

在来自世界不同地区的不同流行病学研究中,化脓性汗腺炎(HS)的患病率差异很大,而南亚地区的数据非常少。

目的

本研究旨在确定孟加拉国达卡HS的患病率。

方法

在孟加拉国达卡的班加班杜·谢赫·穆吉布医科大学医院门诊部(皮肤科除外)对2500名连续就诊患者的健康陪同成年人进行了一项探索性、横断面描述性研究。这是全球化脓性汗腺炎地图集(GHiSA)的一项举措,因此遵循了Bouazzi等人先前发表的方法。结果:在总共2377名陪同人员中,有3人被诊断为HS。点患病率为0.13%(CI:0.04%-0.37%),敏感性为0.1(3/3),特异性为0.1(23/23),阳性预测值(PPV)为0.1(3/3),阴性预测值为0.1(23/23)。HS患者的中位年龄为45.0,中位BMI为28.0。所有3例确诊的HS患者均为男性。

结论

孟加拉国HS的患病率低于西方国家以及其他GHiSA研究(如新加坡、加纳和格陵兰)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abbf/12233970/6c578429ca1c/drm-2025-0000-0000-538444_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abbf/12233970/6c578429ca1c/drm-2025-0000-0000-538444_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abbf/12233970/6c578429ca1c/drm-2025-0000-0000-538444_F01.jpg

相似文献

1
Prevalence of Hidradenitis Suppurativa in Dhaka, Bangladesh: A Hospital-Based Study.孟加拉国达卡化脓性汗腺炎的患病率:一项基于医院的研究。
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000538444.
2
Prevalence of Hidradenitis Suppurativa in Athens, Greece: A Cross-Sectional Study Based on a Validated Questionnaire.希腊雅典化脓性汗腺炎的患病率:一项基于有效问卷的横断面研究。
Dermatology. 2025 Jul 7:1-5. doi: 10.1159/000539758.
3
Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA).荷兰化脓性汗腺炎的患病率:一项作为全球化脓性汗腺炎地图集(GHiSA)一部分的横断面研究。
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000542816.
4
Prevalence of Hidradenitis Suppurativa in Serbia: Validation of a Screening Questionnaire.塞尔维亚化脓性汗腺炎的患病率:一份筛查问卷的验证
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000539877.
5
Prevalence of Hidradenitis Suppurativa in Lund and Gothenburg, Sweden: An Analysis from the Global Hidradenitis Suppurativa Atlas Initiative.瑞典隆德和哥德堡化脓性汗腺炎的患病率:来自全球化脓性汗腺炎地图倡议的分析。
Dermatology. 2025 Jul 7:1-5. doi: 10.1159/000539706.
6
Prevalence of Hidradenitis Suppurativa in Poland.波兰化脓性汗腺炎的患病率。
Dermatology. 2025 Jul 7:1-9. doi: 10.1159/000541951.
7
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.化脓性汗腺炎生活质量(HiSQOL)评分在成年化脓性汗腺炎患者真实世界应用中的验证。
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.
8
Hidradenitis Suppurativa Prevalence in Indonesia: A Cross-Sectional Multicenter Study and Validation of a Screening Questionnaire.印度尼西亚化脓性汗腺炎患病率:一项横断面多中心研究及筛查问卷验证
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000539705.
9
Prevalence of Hidradenitis Suppurativa in Xi'an, China: A Single Center Epidemiological Study.中国西安化脓性汗腺炎的患病率:一项单中心流行病学研究
Dermatology. 2024 Dec 20:1-6. doi: 10.1159/000539019.
10
Prevalence of Hidradenitis Suppurativa in Balangoda, Sri Lanka.斯里兰卡巴朗戈达地区化脓性汗腺炎的患病率。
Dermatology. 2025 Jul 7:1-5. doi: 10.1159/000539336.

引用本文的文献

1
Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies.化脓性汗腺炎的患病率:全球化脓性汗腺炎地图集研究的荟萃分析。
JAMA Dermatol. 2025 Aug 27. doi: 10.1001/jamadermatol.2025.2373.

本文引用的文献

1
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled Analysis.《全球化脓性汗腺炎图谱方法学:汇总分析全球比例》。
Dermatology. 2024;240(3):369-375. doi: 10.1159/000536389. Epub 2024 Feb 14.
2
Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting.格陵兰努克化脓性汗腺炎的患病率:格陵兰环境中化脓性汗腺炎问卷的医生验证。
Acta Derm Venereol. 2023 Jan 10;103:adv00847. doi: 10.2340/actadv.v103.4410.
3
Prevalence of Hidradenitis Suppurativa in Berekum, Ghana.
加纳贝雷库姆化脓性汗腺炎的患病率
Br J Dermatol. 2022 Oct;187(4):586-587. doi: 10.1111/bjd.21234. Epub 2022 Jun 1.
4
Clinico-Epidemiological Characteristics of Hidradenitis Suppurativa: A Retrospective Cohort Study from a Tertiary Care Centre in Northern India.化脓性汗腺炎的临床流行病学特征:来自印度北部一家三级医疗中心的回顾性队列研究
Indian Dermatol Online J. 2021 Jun 20;12(4):561-565. doi: 10.4103/idoj.IDOJ_743_20. eCollection 2021 Jul-Aug.
5
Misdiagnoses and barriers to care in hidradenitis suppurativa: A patient survey.化脓性汗腺炎的误诊及治疗障碍:一项患者调查。
Australas J Dermatol. 2021 Nov;62(4):e592-e594. doi: 10.1111/ajd.13672. Epub 2021 Jul 27.
6
Gender Differences in Service Quality of Upazila Health Complex in Bangladesh.孟加拉国乡卫生综合机构服务质量的性别差异
J Patient Exp. 2021 Apr 13;8:23743735211008304. doi: 10.1177/23743735211008304. eCollection 2021.
7
The epidemiology of hidradenitis suppurativa.化脓性汗腺炎的流行病学
Br J Dermatol. 2020 Dec;183(6):990-998. doi: 10.1111/bjd.19435. Epub 2020 Sep 3.
8
Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.化脓性汗腺炎的延误诊断及其对患者和医疗保健系统的影响。
Dermatology. 2020;236(5):421-430. doi: 10.1159/000508787. Epub 2020 Jul 1.
9
Comorbidities of hidradenitis suppurativa: A review of the literature.化脓性汗腺炎的合并症:文献综述
Int J Womens Dermatol. 2019 Jul 2;5(5):330-334. doi: 10.1016/j.ijwd.2019.06.026. eCollection 2019 Dec.
10
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project.评估化脓性汗腺炎患者的未满足需求:来自全球影响和医疗需求调查(VOICE)项目的结果。
J Am Acad Dermatol. 2020 Feb;82(2):366-376. doi: 10.1016/j.jaad.2019.06.1301. Epub 2019 Jul 3.